Status:
UNKNOWN
Persistent Atrial Fibrillation Ablation and Correlation to Quality of Life
Lead Sponsor:
Newmarket Electrophysiology Research Group Inc
Conditions:
Atrial Fibrillation
Eligibility:
All Genders
18+ years
Brief Summary
The primary objective of this study is to determine the atrial fibrillation burden reduction, or absolute atrial fibrillation burden, associated with improvement in quality of life in patients undergo...
Detailed Description
Atrial fibrillation (AF) is associated with a higher risk of stroke, heart failure and deterioration in patients' quality of life and it also has great effect on health care resource utilization due t...
Eligibility Criteria
Inclusion
- Age \> 18 years
- Patients undergoing first-time or redo AF ablation.
- Persistent or long-standing persistent AF
- Symptomatic atrial fibrillation
- Willing and able to provide informed consent.
- Willing and able to set up and utilize MyCareLink® home monitor and be remotely monitored
- Atrial fibrillation burden equal or more than 80% prior to the ablation
Exclusion
- Paroxysmal AF
- If the patient has had a cardioversion within 2 months of the ablation
- Patients with contraindication to oral or intravenous anticoagulation.
- Contraindication to implantation of an ILR
Key Trial Info
Start Date :
September 10 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2022
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04290559
Start Date
September 10 2018
End Date
September 1 2022
Last Update
March 31 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Southlake Regional Health Centre
Newmarket, Ontario, Canada, L3Y2P9